These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28834758)

  • 1. Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics.
    Kooreman NG; de Almeida PE; Stack JP; Nelakanti RV; Diecke S; Shao NY; Swijnenburg RJ; Sanchez-Freire V; Matsa E; Liu C; Connolly AJ; Hamming JF; Quax PHA; Brehm MA; Greiner DL; Shultz LD; Wu JC
    Cell Rep; 2017 Aug; 20(8):1978-1990. PubMed ID: 28834758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coreceptor blockade targeting CD4 and CD8 allows acceptance of allogeneic human pluripotent stem cell grafts in humanized mice.
    Li J; Li X; Liang C; Ling L; Chen Z; Wong CK; Waldmann H; Lui KO
    Biomaterials; 2020 Jul; 248():120013. PubMed ID: 32278152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of Human Leukocyte Antigen-Mismatched Immune Responses after Transplantation of Human Liver Bud in Humanized Mouse Models.
    Mori A; Murata S; Tashiro N; Tadokoro T; Okamoto S; Otsuka R; Wada H; Murata T; Takahashi T; Seino KI; Taniguchi H
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids.
    Zeleniak A; Wiegand C; Liu W; McCormick C; K R; Alavi A; Guan H; Bertera S; Lakomy R; Tajima A; Cohen H; Wong S; Balikani L; Mizerak B; Bar-Joseph Z; Trucco M; Banerjee I; Fan Y
    Nat Methods; 2022 Oct; 19(10):1306-1319. PubMed ID: 36064772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
    Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
    Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.
    Epperla N; Pasquini M; Pierce K; Drobyski WR; Rizzo JD; Horowitz MM; Saber W; Zellner K; Ramirez S; Bartz K; Raj RV; Hari PN; Hamadani M
    Bone Marrow Transplant; 2017 Jan; 52(1):147-150. PubMed ID: 27479688
    [No Abstract]   [Full Text] [Related]  

  • 8. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
    Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
    Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.
    Yang SF; Xue WJ; Lu WH; Xie LY; Yin AP; Zheng J; Sun JP; Li Y
    Transpl Immunol; 2015 Oct; 33(2):130-9. PubMed ID: 26311302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.
    Bishop MR; Steinberg SM; Gress RE; Hardy NM; Marchigiani D; Kasten-Sportes C; Dean R; Pavletic SZ; Gea-Banacloche J; Castro K; Hakim F; Krumlauf M; Read EJ; Carter C; Leitman SF; Fowler DH
    Br J Haematol; 2004 Sep; 126(6):837-43. PubMed ID: 15352988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity but failure to reject human islet transplants by humanized Balb/c/Rag2gc mice.
    Jacobson S; Heuts F; Juarez J; Hultcrantz M; Korsgren O; Svensson M; Rottenberg M; Flodström-Tullberg M
    Scand J Immunol; 2010 Feb; 71(2):83-90. PubMed ID: 20384859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of human embryonic stem cell-derived endothelial cells in humanized mouse models harboring a human immune system.
    Yang HM; Moon SH; Choi YS; Park SJ; Lee YS; Lee HJ; Kim SJ; Chung HM
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2839-49. PubMed ID: 24092748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Immune Isolation of Allogeneic Mouse Pancreatic Progenitor Cells by a Macroencapsulation Device.
    Faleo G; Lee K; Nguyen V; Tang Q
    Transplantation; 2016 Jun; 100(6):1211-8. PubMed ID: 26982952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstituting Human Cutaneous Regeneration in Humanized Mice under Endothelial Cell Therapy.
    Yang HM; Choi JJ; Kim HN; Yang SJ; Park SJ; Kang C; Chung HM; Lee MR; Kim SJ; Moon SH
    J Invest Dermatol; 2019 Mar; 139(3):692-701. PubMed ID: 30393080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of pluripotent stem cells and their derivatives.
    de Almeida PE; Ransohoff JD; Nahid A; Wu JC
    Circ Res; 2013 Feb; 112(3):549-61. PubMed ID: 23371903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.